Tyrosine-599 of the c-Mpl receptor is required for Shc phosphorylation and the induction of cellular differentiation.
Interaction of thrombopoietin (TPO) with its receptor, c-Mpl, triggers cell growth and differentiation responses controlling primitive haemopoietic cell production and megakaryocytopoiesis. To examine the important receptor domains and signal transduction pathways involved in these cellular responses, c-Mpl cytoplasmic domain truncation and tyrosine substitution mutants were generated. In the myelomonocytic leukaemia cell lines WEHI3B-D+ and M1, ectopic expression of the wild-type c-Mpl receptor induced TPO-dependent cellular differentiation characterized by increased cell migration through agar and acquisition of the morphology and molecular markers of macrophages. Consistent with the concept that proliferative and differentiation signals emanate from distinct receptor domains, the C-terminal 33 amino acids of c-Mpl were dispensable for a proliferative response in Ba/F3 cells but proved critical for WEHI3B-D+ and M1 differentiation. Finer mapping revealed that substitution of Tyr599 by phenylalanine within this c-Mpl domain was sufficient to abolish the normal differentiation response. Moreover, in contrast to the normal c-Mpl receptor, this same mplY599F mutant was also incapable of stimulating TPO-dependent Shc phosphorylation, the association of Shc with Grb2 or c-Mpl and of inducing c-fos expression. Thus activation of components of the Ras signalling cascade, initiated by interaction of Shc with c-Mpl Tyr599, may play a decisive role in specific differentiation signals emanating from the c-Mpl receptor.
Alexander
W S
WS
The Walter and Eliza Hall Institute of Medical Research, Victoria, Australia.
Maurer
A B
AB
Novak
U
U
Harrison-Smith
M
M
D000818:Animals; D002454:Cell Differentiation; D002455:Cell Division; D002460:Cell Line; D017931:DNA Primers; D006801:Humans; D051379:Mice; D016297:Mutagenesis, Site-Directed; D009363:Neoplasm Proteins; D010649:Phenylalanine; D010766:Phosphorylation; D017354:Point Mutation; D016133:Polymerase Chain Reaction; D011518:Proto-Oncogene Proteins / Q000737:chemistry / Q000502:physiology*; D018121:Receptors, Cytokine / Q000502:physiology*; D053628:Receptors, Thrombopoietin; D011994:Recombinant Proteins / Q000378:metabolism; D017384:Sequence Deletion; D015398:Signal Transduction; D013926:Thrombopoietin / Q000378:metabolism* / Q000494:pharmacology*; D014162:Transfection; D014407:Tumor Cells, Cultured; D014443:Tyrosine
D017931:DNA Primers; D009363:Neoplasm Proteins; D011518:Proto-Oncogene Proteins; D018121:Receptors, Cytokine; D053628:Receptors, Thrombopoietin; D011994:Recombinant Proteins; C082218:MPL protein, human; D014443:Tyrosine; D010649:Phenylalanine; D013926:Thrombopoietin